FindTrial
Sign In

Study on simplified citrate anticoagulation hemodialysis scheme suitable for grassroots promotion

Study on simplified citrate anticoagulation hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063874
Enrollment
Unknown
Registered
2022-09-19
Start date
2022-09-06
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis

Interventions

Citrate anticoagulation group:Citrate anticoagulant hemodialysis
Heparin anticoagulation group:Heparin anticoagulant hemodialysis

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)18=Age = 75 2)Dialysis age = 3 months 3) Permanent dialysis access 4)Dialysis blood flow = 200ml/min

Exclusion criteria

Exclusion criteria: 1)Blood flow = 200ml/min 2)severe cardiovascular and cerebrovascular diseases, severe liver dysfunction 3) Hypoxemia (oxygen partial pressure <60 mm Hg) 4)Severe hypotension (<90/60 mmHg)5)Inability to use heparin or citrate anticoagulation 6)Life expectancy < 1 year

Design outcomes

Primary

MeasureTime frame
Coagulation grading of dialysis tubing;dialysis adequacy Kt/V;Adverse events during dialysis;—

Countries

China

Contacts

Public ContactYuehong Li

Beijing Tsinghua Changgung Hospital,School of Clinical Medicine, Tsinghua University

lyha01051@btch.edu.cn13552733500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026